首页>
外国专利>
A method to help predict prognosis after allogeneic hematopoietic stem cell transplantation
A method to help predict prognosis after allogeneic hematopoietic stem cell transplantation
展开▼
机译:异基因造血干细胞移植后有助于预测预后的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
An object of the present invention is to provide a method for predicting the prognosis after transplantation even when the HLA between the donor and the recipient is partially mismatched in allogeneic hematopoietic stem cell transplantation. Among alleles in allogeneic hematopoietic stem cell transplantation, 1 allele or 2 alleles are mismatched among the 4 alleles of HLA genes HLA-A, HLA-B, HLA-C, and HLA-DRB1 in the HLA gene, and the recipe In the case where the ent is a patient with malignant blood disease (excluding myelodysplastic syndrome (MDS)), at the 26th base (rs10925027, C or T) of the base sequence shown in SEQ ID NO: 1 of the NLRP3 gene of the donor or recipient Single nucleotide polymorphism, single nucleotide polymorphism in the 26th base (rs4621666, C or T) of the nucleotide sequence shown in SEQ ID NO: 2, or single nucleotide polymorphism in the relationship of linkage disequilibrium, and the original of the recipient Helps predict prognosis after transplantation using disease type as an indicator.
展开▼
机译:本发明的目的是提供一种即使在同种异体造血干细胞移植中供体和受体之间的HLA部分失配时,也可预测移植后预后的方法。在同种异体造血干细胞移植的等位基因中,HLA基因中HLA-A,HLA-B,HLA-C和HLA-DRB1的4个等位基因中有1个等位基因或2个等位基因错配,以及配方其中ent是患有恶性血液病的患者(骨髓增生异常综合症(MDS)除外),位于供体或受体NLRP3基因SEQ ID NO:1所示碱基序列的第26个碱基(rs10925027,C或T) SEQ ID NO:2所示核苷酸序列的第26个碱基(rs4621666,C或T)的单核苷酸多态性,或连锁不平衡关系中的单核苷酸多态性以及受体原本有助于预测预后移植后以疾病类型为指标。
展开▼